Drugs / modified vaccinia virus Ankara
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00679497 | Jun 2008 → Mar 2010 | HIV infectious disease | Juan A. Arnaiz | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified vaccinia virus Ankara | “a modified vaccinia virus Ankara vector expressing HIV-1 antigens from clade B (MVA-B)” PMID 21907749 ↗ Sep 2011 |
| Known as | MVA-B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00679497 ↗ |
| Modality | Vaccine | “MVA-B as an HIV-1 vaccine candidate” PMID 21907749 ↗ Sep 2011 |
| Route | Intramuscular | “3 intramuscular injections (1×10(8)pfu/dose) of MVA-B” PMID 21907749 ↗ Sep 2011 |